107 related articles for article (PubMed ID: 3928960)
1. Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis.
Ell C; Braun J; König HJ; Domschke S; Domschke W
Klin Wochenschr; 1985 Jun; 63(12):572-4. PubMed ID: 3928960
[TBL] [Abstract][Full Text] [Related]
2. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
[TBL] [Abstract][Full Text] [Related]
3. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
[TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability of high-dose metoclopramide.
Taylor WB; Bateman DN
Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.
Taylor WB; Proctor SJ; Bateman DN
Br J Clin Pharmacol; 1984 Nov; 18(5):679-84. PubMed ID: 6508977
[TBL] [Abstract][Full Text] [Related]
6. Optimizing metoclopramide control of cisplatin-induced emesis.
Meyer BR; Lewin M; Drayer DE; Pasmantier M; Lonski L; Reidenberg MM
Ann Intern Med; 1984 Mar; 100(3):393-5. PubMed ID: 6538075
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.
McDermed JE; Cohen JL; Joseph C; Strum SB
J Clin Oncol; 1985 Oct; 3(10):1400-8. PubMed ID: 3900303
[TBL] [Abstract][Full Text] [Related]
8. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity.
Fukushima K; Okada A; Oe H; Hirasaki M; Hamori M; Nishimura A; Shibata N; Sugioka N
Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):193-203. PubMed ID: 28913815
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
[TBL] [Abstract][Full Text] [Related]
12. [Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy].
Vergin H; Köhler M; Senn HJ
Arzneimittelforschung; 1984; 34(11):1595-7. PubMed ID: 6543137
[TBL] [Abstract][Full Text] [Related]
13. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
Martín M; Díaz-Rubio E
Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
[TBL] [Abstract][Full Text] [Related]
15. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
16. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
Seng KT; Tiong CE; Hiang TC
Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
18. [Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach].
Brechot JM; Dupeyron JP; Guyon F; Delfour C; Delattre C; Lebeau B; Rochemaure J
Presse Med; 1988 Jun; 17(22):1147-9. PubMed ID: 2840652
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
Pollera CF; Conti EM; De Nigris A; Calabresi F
Oncology; 1987; 44(2):73-7. PubMed ID: 3554084
[TBL] [Abstract][Full Text] [Related]
20. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
Saller R; Hellenbrecht D
Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
